Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

43.99
Delayed Data
As of Jul 22
 -0.41 / -0.92%
Today’s Change
26.02
Today|||52-Week Range
51.67
-1.98%
Year-to-Date
3 Stocks We're Buying Again
Jul 21 / MotleyFool.com - Paid Partner Content
5 Things Celldex Therapeutics, Inc. Wants You to Know
Jul 13 / MotleyFool.com - Paid Partner Content
3 Primary Ways Researchers Are Combatting Cancer
Jul 16 / MotleyFool.com - Paid Partner Content
AbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S.
Jul 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close44.40
Today’s open44.31
Day’s range43.93 - 44.83
Volume692,805
Average volume (3 months)935,429
Market cap$6.2B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-18.08%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book8.96

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+0.09+0.06%
OPKOPKO Health Inc+0.08+0.81%
MNKMallinckrodt Plc-1.04-1.54%
ALKSAlkermes Plc+0.83+1.69%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

Partner Offers

Search for Jobs